Published in Ann Rheum Dis on January 01, 1994
The human lumbar intervertebral disc: evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration. J Clin Invest (1996) 3.89
Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis (2001) 2.18
Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest (1995) 1.77
Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis. Ann Rheum Dis (1995) 0.91
Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis. Ann Rheum Dis (2001) 0.84
The value of synovial fluid analysis in the assessment of knee joint destruction in arthritis in a three year follow up study. Ann Rheum Dis (1999) 0.78
Changes in cartilage proteoglycan aggrecan after intra-articular injection of interleukin-1 in rabbits: studies of synovial fluid and articular cartilage. Ann Rheum Dis (1996) 0.75
COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem (1992) 2.18
A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res (1992) 2.12
Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease. J Clin Invest (1992) 2.10
Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum (1991) 1.92
Quantification of keratan sulfate in blood as a marker of cartilage catabolism. Arthritis Rheum (1985) 1.82
Modulation of native chondroitin sulphate structure in tissue development and in disease. J Cell Sci (1990) 1.57
Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis. Ann Rheum Dis (1994) 1.45
Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis (1985) 1.41
Increased levels of proteoglycan fragments in knee joint fluid after injury. Arthritis Rheum (1989) 1.38
Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol (1989) 1.34
Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients. Relationship to synovitis mass and morning stiffness. Arthritis Rheum (1987) 1.23
Proteoglycan fragments in joint fluid. Influence of arthrosis and inflammation. Acta Orthop Scand (1992) 1.21
Inflammation and cartilage metabolism in rheumatoid arthritis. Studies of the blood markers hyaluronic acid, orosomucoid, and keratan sulfate. Arthritis Rheum (1990) 1.21
Levels of circulating tumor necrosis factor alpha and interleukin-6 in patients with rheumatoid arthritis. Relationship to serum levels of hyaluronan and antigenic keratan sulfate. Arthritis Rheum (1993) 1.18
Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis. Br J Rheumatol (1992) 1.15
A method for the quantification of cartilage proteoglycan structures liberated to the synovial fluid during developing degenerative joint disease. Scand J Clin Lab Invest (1985) 1.09
The quantitation of a native chondroitin sulfate epitope in synovial fluid lavages and articular cartilage from canine experimental osteoarthritis and disuse atrophy. Arthritis Rheum (1993) 1.08
Serum hyaluronate level as a predictor of radiologic progression in early rheumatoid arthritis. Arthritis Rheum (1991) 1.02
Serum keratan sulfate. Quantitative and qualitative comparisons in inflammatory versus noninflammatory arthritides. Arthritis Rheum (1991) 1.00
Release of cartilage macromolecules into the synovial fluid in patients with acute and prolonged phases of reactive arthritis. Arthritis Rheum (1993) 0.98
Involvement of nonarticular cartilage, as demonstrated by release of a cartilage-specific protein, in rheumatoid arthritis. Arthritis Rheum (1989) 0.97
Joint fluid carboxy-terminal type II procollagen peptide as a marker of cartilage collagen biosynthesis. Osteoarthritis Cartilage (1993) 0.91
Keratan sulphate in rheumatoid arthritis, osteoarthritis, and inflammatory diseases. Ann Rheum Dis (1992) 0.84
Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis. J Clin Invest (1994) 1.27
Inflammation and cartilage metabolism in rheumatoid arthritis. Studies of the blood markers hyaluronic acid, orosomucoid, and keratan sulfate. Arthritis Rheum (1990) 1.21
Contents and distributions of the proteoglycans decorin and biglycan in normal and osteoarthritic human articular cartilage. J Orthop Res (1996) 1.05
Immunoelectron microscopic studies of type X collagen in endochondral ossification. J Cell Biol (1989) 1.03
Cartilage macromolecules and the calcification of cartilage matrix. Anat Rec (1989) 1.00
Biological markers in rheumatoid arthritis. Semin Arthritis Rheum (1994) 0.99